Skip to main content
. 2020 Jun 24;2020:1536714. doi: 10.1155/2020/1536714

Figure 1.

Figure 1

Timeline of antibiotic therapies, antibiotic susceptibility pattern of the primary pathogen (Burkholderia cepacia complex (Burkholderia multivorans)), and colony forming units (CFU) of this pathogen relative to the initiation of high-dose inhaled nitric oxide therapy on day 1. The antibiotic susceptibility data are reported as susceptible S, intermediate I, or resistant R. Due to limitations in commercial identification systems to reliably distinguish among species of the Burkholderia cepacia complex, Burkholderia multivorans identification was reported as the Burkholderia cepacia complex by our clinical microbiology laboratory. The patient's isolates had been confirmed as Burkholderia multivorans by the Burkholderia cepacia Research Laboratory and Repository (Ann Arbor, Michigan, USA) within the prior year.